AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica production deal

AstraZeneca is on the hook for millions of doses of the University of Oxford's front-runner COVID-19 vaccine candidate, assuming it proves effective. To fill those orders, the British drugmaker has agreed to a short-term manufacturing deal that will help it bridge the gap.